Following completion of preclinical testing, AxImmune intends to file an IND with the FDA. AxImmune anticipates commencing clinical trials in Q4 2019. Plans are underway to conduct clinical trials at multiple sites... AxImmune, Inc. is developing..
Relevance: 15.865397